These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25826538)

  • 1. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 2. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
    Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
    Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
    Riella LV; Sheridan AM
    Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
    Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
    Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival.
    Lee BT; Kumar V; Williams TA; Abdi R; Bernhardy A; Dyer C; Conte S; Genovese G; Ross MD; Friedman DJ; Gaston R; Milford E; Pollak MR; Chandraker A
    Am J Transplant; 2012 Jul; 12(7):1924-8. PubMed ID: 22487534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
    Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
    Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
    Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
    Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Real World Impact of APOL1 Variants on Kidney Transplantation.
    Chandraker A
    Transplantation; 2016 Jan; 100(1):16-7. PubMed ID: 26566059
    [No Abstract]   [Full Text] [Related]  

  • 10. The AJT Report: news and issues that affect organ and tissue transplantation. Genetic factor may limitkidney donation.
    Pondrom S
    Am J Transplant; 2012 Nov; 12(11):2865-6. PubMed ID: 23107266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
    Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
    Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 risk variants, race, and progression of chronic kidney disease.
    Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
    N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy.
    Larsen CP; Beggs ML; Walker PD; Saeed M; Ambruzs JM; Messias NC
    Am J Kidney Dis; 2014 Jul; 64(1):161-3. PubMed ID: 24731740
    [No Abstract]   [Full Text] [Related]  

  • 15. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health disparities in kidney disease--emerging data from the human genome.
    Williams WW; Pollak MR
    N Engl J Med; 2013 Dec; 369(23):2260-1. PubMed ID: 24206461
    [No Abstract]   [Full Text] [Related]  

  • 17. The APOL1 gene and allograft survival after kidney transplantation.
    Reeves-Daniel AM; DePalma JA; Bleyer AJ; Rocco MV; Murea M; Adams PL; Langefeld CD; Bowden DW; Hicks PJ; Stratta RJ; Lin JJ; Kiger DF; Gautreaux MD; Divers J; Freedman BI
    Am J Transplant; 2011 May; 11(5):1025-30. PubMed ID: 21486385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined Effects of GSTM1 Null Allele and APOL1 Renal Risk Alleles in CKD Progression in the African American Study of Kidney Disease and Hypertension Trial.
    Bodonyi-Kovacs G; Ma JZ; Chang J; Lipkowitz MS; Kopp JB; Winkler CA; Le TH
    J Am Soc Nephrol; 2016 Oct; 27(10):3140-3152. PubMed ID: 26940095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.
    Estrella MM; Li M; Tin A; Abraham AG; Shlipak MG; Penugonda S; Hussain SK; Palella FJ; Wolinsky SM; Martinson JJ; Parekh RS; Kao WH
    Clin Infect Dis; 2015 Feb; 60(4):646-52. PubMed ID: 25281610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.